August 3, 2020 - Contract Pharma
PPD, Inc. has signed a new three-year agreement with Pfizer to provide drug development services to advance Pfizer’s portfolio. Pfizer has the right to extend the term for additional two-year periods. Financial details were not disclosed.
August 4, 2020 - Contract Pharma
Partner Therapeutics, Inc. will receive a $35 million milestone-based Other Transaction Agreement with the U.S. Department of Defense (DOD) to fund two clinical studies of inhaled Leukine in patients with COVID-19 associated acute hypoxemia. The program will evaluate the effect of Leukine in improving clinical outcomes, including oxygenation and percent of patients intubated.
August 5 - Contract Pharma
Johnson & Johnson’s Janssen Pharmaceutical Companies have entered into an agreement with the U.S. government for the large scale domestic manufacturing and delivery in the U.S. of 100 million doses of Janssen's SARS-CoV-2 investigational vaccine, Ad26.COV2.S, for use in the U.S. following approval or Emergency Use Authorization by the FDA.
August 7, 2020 - Fierce Pharma
A third spinal muscular atrophy treatment is set to debut with the FDA’s approval for Roche’s Evrysdi, formerly known as risdiplam. The medicine offers at-home dosing for patients, potentially giving it an edge versus the competition during the COVID-19 pandemic.